InvestorsHub Logo

fung_derf

10/03/18 10:31 AM

#9389 RE: Big ass Juan #9388

Geez! I hope not! I think fair value is around $1.25 or so right now. I don't see them as profitable until 2020 though

RITE AID CORPORATION Currency USD Scale 1,000,000

Operator 06/02/2018*
Total Debt / Enterprise Value - TTM 0.75

Total Debt -
/

Consolidated Market Value 1,225.25

Shares Outstanding Common 1065.434
Previous Day Closing Price * 1.15

Cash - Generic – -
Total Debt + -
Preferred Stock + 0.00
Minority Interest + 0.00

fung_derf

10/03/18 10:35 AM

#9390 RE: Big ass Juan #9388

I think I need to lower my evaluation...


Outlook for Fiscal 2019

Rite Aid is confirming its fiscal 2019 outlook for revenues, same store
sales, Adjusted EBITDA and capital expenditures. Rite Aid expects
revenues to be between $21.7 billion and $22.1 billion in fiscal 2019
with same store sales expected to range from an increase of 0.0 percent
to 1.0 percent over fiscal 2018. Adjusted EBITDA (which is reconciled to
net loss in the attached table) is expected to be between $540.0 million
and $590.0 million. Capital expenditures are expected to be
approximately $250 million.

Net loss is now expected to be between $440 million and $485 million,
which is higher than previously announced due primarily to the
impairment charges incurred this quarter. Additionally, during the
second quarter of fiscal 2019, we modified our definition of adjusted
net (loss) income to reflect the add back of all amortization rather
than the amortization of EnvisionRx intangible assets only. After giving
effect to the change in our definition, adjusted net (loss) income per
share is now expected to be between a loss of $0.03 and income of $0.01.

wodehouse

10/07/18 4:14 PM

#9395 RE: Big ass Juan #9388

I would hope a merger would avoid that.